Measured Wealth Private Client Group LLC Purchases 2,798 Shares of Cardinal Health, Inc. $CAH

Measured Wealth Private Client Group LLC grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 182.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,334 shares of the company’s stock after acquiring an additional 2,798 shares during the period. Measured Wealth Private Client Group LLC’s holdings in Cardinal Health were worth $916,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Redhawk Wealth Advisors Inc. boosted its position in shares of Cardinal Health by 0.5% during the 4th quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock valued at $1,902,000 after purchasing an additional 48 shares in the last quarter. HF Advisory Group LLC increased its holdings in Cardinal Health by 0.9% in the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock worth $1,074,000 after purchasing an additional 49 shares in the last quarter. Kathmere Capital Management LLC lifted its stake in Cardinal Health by 1.2% in the first quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock valued at $896,000 after buying an additional 49 shares during the period. Hillsdale Investment Management Inc. lifted its stake in Cardinal Health by 0.9% in the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock valued at $1,184,000 after buying an additional 50 shares during the period. Finally, V Square Quantitative Management LLC boosted its holdings in shares of Cardinal Health by 2.6% during the 1st quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock worth $423,000 after buying an additional 50 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on CAH. Weiss Ratings downgraded shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. William Blair initiated coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating on the stock. Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a research note on Friday, May 1st. Wells Fargo & Company reduced their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Finally, Evercore decreased their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $250.07.

Get Our Latest Report on Cardinal Health

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $221.09 on Thursday. The business’s 50 day simple moving average is $218.69 and its two-hundred day simple moving average is $214.20. The firm has a market cap of $51.78 billion, a P/E ratio of 33.81, a PEG ratio of 1.11 and a beta of 0.49. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $243.21.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter in the previous year, the company posted $2.35 earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities analysts forecast that Cardinal Health, Inc. will post 10.77 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were paid a dividend of $0.5158 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date was Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is presently 31.50%.

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

See Also

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.